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Although human la or class II histocompatibility antigens were initially thought
to be restricted to cells of the immune system, studies have shown the presence
of la antigens on malignant melanomas (1-3) and other cell types having no
known immune functions (3-6) . While la antigens can be detected on most
melanoma biopsy specimens and melanoma cell lines (7, 8), normal melanocytes
lack constitutive la expression (9), either in vivo or in vitro . To investigate the
relationship of la expression in melanomas to malignant transformation, we
infected melanocytes with transforming amphotropic pseudotypes of Harvey
murine sarcoma virus (Ha-MSV)' or Kirsten murine sarcoma virus (Ki-MSV) .
The Ha-MSV and Ki-MSV retroviruses contain oncogenes of the ras gene family,
and were chosen because our previous studies (10) indicated that 10% of cultured
melanomas have an activated ras gene allele (either Ha-ras or N-ras), and no
other conclusive perturbation (i.e ., rearrangement or amplification) in 15 other
known oncogenes (A . P . Albino, unpublished results) .
Materials and Methods
Tissue Culture.
￿
Melanocytes and other cell lines were derived as described previously
(3) . Cultures were maintained in Eagle's MEM supplemented with 2 mM glutamine, 1
nonessential amino acids, 100 U/ml penicillin and 10% FCS . For culturing melanocytes,
the medium was supplemented (11) with 10-s M cholera toxin (Schwartz/Mann Biologi-
cals, Orangeburg, NY) and 10 ng/ml 12-o-tetradecanoyl phorbol-l3-acetate (TPA) (Con-
solidated Midland Corp ., Brewster, NY) . Melanocyte cultures were used during early
passages (less than four) .
Virological Techniques.
￿
Viral stocks were isolated from NIH 3T3 cells infected with
4070A amphotropic murine leukemia virus (MuLV) (12), or from Ki-MSV, Ha-MSV, or
Ki-MSV temperature sensitive (ts) mutant-infected NIH 3T3 nonproducer clones super-
infected with 4070A amphotropic helper MuLV (13, 14, and A . I . Oliff, unpublished
data) . The Ki-MSV and Ha-MSV pseudotypes were collected as fresh 24-h cell-free
supernatant fluids and frozen at -70°C until use . ^-105 melanocytes were pretreated for
60 min with DEAE/dextran (25 Ag/ml), washed, then incubated with virus at a multiplicity
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of infection of one. Transforming activity of virus produced by infected cells was
determined by focus assays on NIH 3T3 cells (15). Infectious virus produced by melano-
cytes infected with 4070A amphotropic virus was quantitated by titrating the virus on
NIH 3T3 cells and determining the expression of MuLV p30 gag gene protein in the
cytoplasm. The ability of infected cells to form growing colonies in soft agar (16) and to
form infectious centers on NIH 3T3 cells(17) were determined as described. Mouse NIH
3T3 cells infected with the Ki-MSV is mutant showed a 10'-fold decrease in focus
formation at the nonpermissive temperature.
Northern Blot Analysis.
￿
Total RNA was prepared as described (18), fractionated by
electrophoresis on a 1 .0% agarose gel (3 Ag/lane) in the presence of formaldehyde (19),
and transferred to Nytran membranes (Schleicher and Shuell, Keene, NH). Probes were
"P-labeled and hybridized to membranes as described (10).
Serological Reagents. The following mouse mAb were used for serological testing:
L243 (recognizes a nonpolymorphic determinant on human la molecules [20]), W6/32
(recognizes monomorphic determinants on HLA-A,B,C molecules [21]), C350 (recognizes
a cell-surface antigenic determinant expressed only by pigmented cells; A. N . Houghton,
T. Thomson, and F. Real, unpublished results), CF21 and TA99 (recognize antigenic
determinants present in mature melanosomes [22, 23]), R24 (recognizes GDS ganglioside
[24]), B5.2 (recognizes a chondroitin sulfated proteoglycan [8]), and B2.6 (recognizes an
antigenic determinant present on the cell surface of a subset of melanomas and astrocy-
tomas; A. P. Albino and G. Cairncross, unpublished results). Human serum containing a
natural antibody detecting the MEL-1 differentiation antigen of melanomas and melano-
cytes has been reported (25). Rabbit anti-Rauscher MuLV group-specific p30 serum (26)
and rat anti-p21 mAb Y13-259 (27) were generous gifts of Drs. Paul V . O'Donnell and
Mark E. Furth, respectively, of Sloan-Kettering Memorial Cancer Center.
Immunoprecipitation Analysis.
￿
Cells were radiolabeled by metabolic incorporation of
["S]methionine (New England Nuclear, Boston, MA: 1,000 Ci/mmol) using 250 ACi in
10 ml of methionine-free MEM containing I % FCS for 16 h. Labeled cells were extracted
as described (10). Immunoprecipitation was carried out by mixing a portion of the cell
extract (10 X 106 cpm) with 1 jul of undiluted ascites fluid Y13-259 (anti-p21), W6/32
(anti-HLA-A,B,C) or L243 (anti-la) and 15 I,l of rabbit anti-mouse immunoglobulin
serum (Cappel Laboratories, Cochranville, PA). Immune complexes were isolated with
protein A-Sepharose C14B (Pharmacia Fine Chemicals, Piscataway, NJ) and the labeled
components were detected by SDS-PAGE and fluorography as described (10).
Serological Assays. The protein A and anti-mouse immunoglobulin hemadsorption
assays were performed as described (3) . Indicator cells were prepared by conjugating
either protein A (Pharmacia Fine Chemicals) or the immunoglobulin fraction of rabbit
anti-mouse y heavy chain (Dako Corp., Santa Barbara, CA) to human O+ erythrocytes
with 0 .01 % chromium chloride. Assays were performed in Falcon 3040 microtest plates
(Falcon Labware, Oxnard, CA). Target cells (plated 1-2 d previously) and serial antibody
dilutions were incubated for I h at 37'C. Target cells were then washed and indicator
cells were added for 45 min . Target cells were washed again to remove nonadherent
indicator cells. Titers were defined as the antibody dilution showing 20% positive (roset-
ted) target cells as evaluated under light microscopy. Indirect immunofluorescence assays
were performed as described (8). Cells were fixed in equal volume of methanol/acetone,
incubated with serially diluted mouse mAb (see Table I) then with goat anti-mouse
immunoglobulins conjugated with fluorescein (Cooper Biomedical, Malvern, PA) at a
dilution of 1 :40 in PBS. Double-labeling experiments, performed to assess whether
individual infected melanocytes expressed both la antigens and viral p21 protein, were
done as follows: melanocytes were incubated with anti-p21 rat mAb (at a dilution that did
not detect endogenous human p21 proteins) followed by goat anti-rat IgG labeled with
rhodamine (Cooper Biomedical) diluted 1 :25 with PBS. After extensive washing the cells
were then incubated with anti-la mouse mAb followed by goat anti-mouse IgG labeled
with fluorescein (Cooper Biomedical) diluted 1 :25 with PBS. To detect expression of
MuLV p30 gag protein, fixed cells wre incubated with rabbit anti-Rauscher-MuLV
group-specific p30 serum at a dilution of 1 :25, washed, then incubated with goat anti-1712
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rabbit IgG labeled with fluorescein (Coopers Biomedical) diluted 1:25 with PBS. Cells
were examined with a Nikon fluorescence microscope using either blue or green filters.
Induction Assays. Assays for la antigen induction were performed in Falcon 3034
plates (Falcon Labware). Target melanocytes were plated at 200 cells/well in MEM
medium plus 7.5% FCS. 2-4 h after plating, spent culture supernatant was added to the
medium in each well to give a final dilution of 1:3 (vol/vol). Cells were then cultured at
37 °C in 5% C02, and serological assays were performed as described above at days 3 and
6 using L243 mouse mAb. Natural IFN-'y was from Interferon Sciences, Inc., New
Brunswick, NJ.
Results
Fig. I shows the results of Ki-MSV and Ha-MSV infection on the morphology
and growth characteristics of human melanocytes. 2 wk after infection, islands
of Ki-MSV- or Ha-MSV-infected melanocytes appeared that had a distinct mor-
phology. Uninfected melanocytes grow as bipolar spindle-shaped cells without
much intercellular contact (Fig. 1A). Cells infected with the amphotropic MuLV
helper virus had the same morphology as normal melanocytes (Fig. I B) . Mcla-
nocytes infected with either Ki-MSV or Ha-MSV were more polygonal and grew
as clusters of cells with a tendency to pile up (Fig. 1 C). Identical changes were
observed in four independently Ki-MSV- or Ha-MSV-infected melanocyte cul-
tures. ^"90% of melanocytes infected with amphotropic MuLV, Ki-MSV, or Ha-
MSV expressed cytoplasmic viral p30 gag gene protein. At 2 wk, 65% of the
cells infected with Ki-MSV or Ha-MSV also expressed detectable levels of viral
p21 protein. A similar percentage of Ki-MSV- or Ha-MSV-infected cells formed
infectious centers on NIH 3T3 cells, indicating the production of mature
transforming virus. Supernatants from Ki-MSV- or Ha-MSV-infected cultures
contained _102-104 infectious focus forming units (FFU) per milliliter as assayed
on NIH 3T3 cells. Supernatants from amphotropic MuLV-infected cells pro-
duced -10' infectious non-focus forming units per milliliter. Northern blot
analysis confirmed the presence of Ha-ras or Ki-ras specific viral messenger
RNAs.
Proliferation of melanocytes in vitro depends upon the addition of exogenous
growth factors to the medium (11). Factors that support the growth of melano-
cytes include TPA (11). and growth factors derived from fetal fibroblasts,
astrocytoma and melanoma cells (28). In the absence of growth factors, mela-
nocytes rapidly become senescent anddie. In contrast, cultured melanomas grow
vigorously in the absence of TPA, suggesting that malignant transformation of
melanocytes is associated with the acquisition of autonomy from exogenous
growth factors. In the presence of TPA, the growth rate of melanocytes infected
with Ki-MSV or Ha-MSV was comparable to uninfected control cells and to a
companion culture infected with amphotropic MuLV . In the absence of exoge-
nous growth factors, uninfected melanocytes and melanocytes infected with
amphotropic MuLV died rapidly (within 6-12 d). Ki-MSV-and Ha-MSV-infected
cultures also become senescent, but at a reduced rate (within 2-4 wk). Thus,
expression of ras oncogenes does not induce stable, growth factor-independent
melanocyte cell lines.
Melanocytes cultured in the presence of TPA do not form colonies in semisolid
agar. This is also true of melanocytes infected with amphotropic MuLV. InFIGURE 1 .
￿
Morphology of cultured melanocytes. Photomicrographs of (A) uninfected mela-
nocytes, (B) 4070A amphotropic MuLV-infected melanocytes, and (C) Ki-MSV-infected
melanocytes . X 220 . Cells shown in B andC are 3-wk postinfection .
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contrast, Ki-MSV- and Ha-MSV-infected melanocytes acquire an anchorage-
independent phenotype and initiate colonies of proliferating cells in soft agar
assays at a frequency of 0.04-0.1%, but require TPA to do so. We could not
determine whether these cells were also tumorigenic in nu/nu mice, as these cells
release high amounts of infectious MuLV/MSV, which causes leukemias and
sarcomas in mice. Melanocytes infected with ras-containing viral vectors that do
not result in productive infections are being examined to determine if these cells
are tumorigenic.
Previous work (9) has shown that melanocytes do not normally express la
antigens, although la expression can be reversibly induced in melanocytes by
IFN-y. A range of other substances were tested for melanocyte la-inducing
activity, including IFN-a and IFN-,8, but only IFN-y was active (9). Table I shows
the results of serological tests for expression of a range of cytoplasmic and cell
surface antigens, including class I and class II histocompatibility antigens in
infected and noninfected melanocytes. Infection with Ha-MSV or Ki-MSV in-
duced the strong expression of class II antigens in melanocytes within 5-10 d.
Induction of la antigens was observed in four independently derived melanocyte
cultures. Immunological analysis by dual-labeling fluorescence indicated that the
cells expressing la antigens also expressed viral p21 protein. Ki-MSV- and Ha-
MSV-infected melanocytes were tested over a period of 6 mo with no change in
la expression. Class II antigens were not induced in melanocytes infected with
amphotropic MuLV. Little or no change was detected in the expression of class
I histocompatibility antigens in melanocytes infected with Ki-MSV, Ha-MSV, or
amphotropic MuLV. To determine whether la induction by ras oncogenes was
a reversible phenomenon, as in IFN-y-treated melanocytes, or a permanent one,
as in melanomas, we studied melanocytes infected with a is mutant of Ki-MSV
(14). Fig. 2 shows that both the a (34 kD) and a (28 kD) chains of the la
bimolecular complex were expressed in equivalent amounts at both permissive
and nonpermissive temperatures, suggesting that once la antigen expression has
been established, continued expression is not dependent on functional viral ras
p21 . It is, of course, possible that minimal amounts of functional p21 exist at the
nonpermissive temperature, which may be sufficient to maintain the inductive
effect on la antigens.
To determine whether la expression can be induced in other cell types, early-
passage human fetal foreskin ftbroblasts and early-passage SK-MEL-93 (DX-2,
an la- melanoma [29]) cells were infected with Ki-MSV. No la antigen induction
was induced in these cells even though 90% of the cells were producing Ki-MSV
p21 and infectious transforming virus. Both cell types (whether infected with Ki-
MSV or not) expressed la after induction by IFN-y.
To determine which class II subloci were activated, cytoplasmic RNA was
analyzed by northern blotting with class II probes. Ki-MSV-infected melanocytes
expressed RNA specific for at least three class II a gene loci, DP, DQ, and DR.
(see Fig. 3); uninfected melanocytes and melanocytes infected with amphotropic
MuLV did not express la antigens or RNA specific for class II genes. Immuno-
precipitation analysis (Fig. 4) with extracts of metabolically labeled cells showed
similar patterns of class I and II antigen expression in melanoma cells and Ki-
MSV-infected melanocytes.V O
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FIGURE 2 .
￿
Immunoprecipitation of la antigens and viral p21 protein . Autoradiograms of
immunoprecipitates obtained with extracts of [s5S]methionine-labeled melanocytes infected
with is mutant ofKi-MSV and grown at 33°C or 39°C for 8 wk before analysis by SDS-PAGE .
Lanes 1, 4 : unrelated mouse mAb ; lanes 2, 5 : Y13-259 mAb (anti-p21); lanes 3, 6 : L243 mAb
(anti-la) .
FIGURE 3 .
￿
Northern blot analysis of class II gene expression . Blots were hybridized to the
following '2P-labeled DNA fragments ofbetween 500and 2,500 nucleotides in length, isolated
as described (43) . DP-a (pDS-a3,8 ; a gift of H. Erlich, Cetus Corp ., Emeryville, CA); DQ-a
(pDQ10-8 [ref. 44]) ;and DR-a(pDRH2 [refs . 45,461). Positions of the 28 Sand 18 Sribosomal
RNA are indicated . Lanes 1 : uninfected melanocytes ; 2 : Ki-MSV-infected melanocytes ; 3 :
4070Aamphotropic helper Mul-V-infected melanocytes ; and 4 : SK-MEL-147 melanoma .
Although T lymphocytes are the only cell type known to produce IFN-y, we
considered the possibility that melanocytes synthesize IFN-y after infection with
Ki-MSV or Ha-MSV . A sensitive la-induction assay, detecting as little as 1-5
U/ml of IFN-y (9), was used to assay culture supernatants of Ki-MSV-infected
melanocytes. Control and infected melanocytes were cultured for 4 d, andALBINO ET AL .
￿
171 7
FIGURE 4 .
￿
Immunoprecipitation of la and HLA-A,B,C antigens . Autoradiograms of immu-
noprecipitates obtained with extracts of the indicated cells labeled with ['SS]methionine for 16
h and analyzed by SDS-PAGE . A, uninfected melanocytes ; B, Ki-MSV-infected melanocytes;
C, SK-MEL-47 melanoma . B-2-M, B-2 microglobulin Lanes : 1, unrelated mousemAb (control) ;
2, W6/32 mAb (anti-HLA-A,B,C) ; 3, L243 mAb (anti-la) . Molecular mass standards : ovalbu-
min, 43 kD ; a-chymotrypsinogen, 25 kD ; 0-lactoglobulin, 18 kD .
supernatants were collected, centrifuged to remove virus particles, then added
to target melanocytes. Supernatants from uninfected melanocytes to which IFN-
y was added (to final concentrations of 5 and 50 U/ml) served as an additional
control for these experiments . Target cells were assayed for the expression of la
antigens by mixed hemadsorption assays after 3 and 6 d of incubation with
supernatants . Supernatants from Ki-MSV-infected melanocytes or uninfected
control melanocytes were unable to induce expression of la antigens, whereas
supernatants to which IFN-y had been added induced la expression . Therefore,
we have no evidence for the production of IFN-y or other la-inducing factors
by Ki-MSV infected melanocytes .
Melanocytes and melanomas have a number of distinguishing characteristics .
In some cases, these are restricted to melanocytes and melanomas (3, 8, 22) ; in
other cases, they are shared by other cell types of neuroectodermal origin (8,
30-32) . Tests of Ki-MSV- and Ha-MSV-infected melanocytes for the expression
of these differentiation-related phenotypic characteristics are shown in Table I .
There was essentially no change in differentiation-related characteristics upon
infection with either amphotropic MuLV or ras oncogene-containing viruses .
Infected melanocytes (a) remained pigmented, indicating the presence of mela-
nin ; (b) had tyrosinase levels that were comparable to uninfected cells ; (c)
expressed melanocytic markers TA99 and CF21, two antigens characteristic of
mature melanosomes (22, 23); (d) expressed a cell surface glycoprotein, detected
by mAb C350, found only on melanocytes and pigmented melanoma cells (A .
N . Houghton, unpublished data) ; and (e) continued to express adenosine deam-
inase binding protein (ADA BP), which is not expressed by melanoma cells (A .
N . Houghton, unpublished data) . One well-characterized melanoma marker
whose expression did change was GDS disialoganglioside . WhileGDS is expressed
at low levels on the surface of melanocytes, it is a predominant membrane171 8
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ganglioside ofmelanomas (8, 24, 33). Melanocytes infected with Ki-MSV showed
a substantial increase in the expression of GDS as measured by immune-rosetting
assays. Direct quantitation ofGDS expression using' 2'I-labeled antibody indicated
that the level of GDS in Ki-MSV-infected melanocytes increased by >5-10-fold
over uninfected melanocytes or melanocytes infected with amphotropic MuLV.
Discussion
The constitutive expression ofla antigens in melanoma, in contrast to the lack
ofla expression by melanocytes, can be accounted for in two ways. la expression
could be a characteristic of an unidentified early progenitor in the melanocyte
pathway that is a target for melanocyte transformation; expression of la by
melanoma cells would simply reflect their origin from an Ia'' normal cell popu-
lation . This idea comes from the finding of Houghton et al. (3) that cultured
melanomas from different individuals can be classified into three general groups
according to antigenic and morphological features, and that these characteristics
appear to correspond to different stages in melanocyte differentiation. The other
possibility is that melanomas arise from la- precursors and that induction of la
expression is one ofthe consequences ofmalignant transformation. The present
study provides support for this possibility, i.e., rapid la induction after Ha-MSV
or Ki-MSV infection. Once la is induced, however, the presence of functional
p21 transforming protein does not seem to be essential for the continued
expression of la, as indicated by the results with is viral ras mutants. The
induction of la expression in melanocytesby IFN-y and viral ras appears to have
a high degree of specificity. With regard to soluble factors, only IFN-y has la-
inducing activity (9). Usingamphotropic MuLV constructs with other oncogenes,
we have not found la in melanocytes expressing myc, src, orfms, emphasizing the
unusual capacity of viral ras to activate la expression. There are several indica-
tions that la induction by activated ras and by IFN-y are mediated through
separate pathways: (a) la induction by viral ras does not appear to involve IFN-
y, (b) la- melanomas that are inducible by IFN-y remain la- after introducing
viral ras, and (c) fibroblasts expressing viral ras do not express la even though
they do so after IFN-y. At least two trans-acting factors regulating class II gene
expression in lymphoid cells have been proposed (34, 35). Both factors are
necessary for expression of three class II subloci, DP, DQ, and DR. In melano-
cytes, activated ras genes and IFN-y induce products of these three loci in a
coordinate fashion, excluding the possibility that differential activation of class
II genes is the basis for differences in la induction by IFN-y and viral ras.
Normal diploid human cells, in contrast to rodent cells, have been difficult to
transform with activated ras oncogenes as the sole transforming agent (36, 37).
In no instance have such cells formed tumors in nu/nu mice. However, in systems
where cells have either a genetically determined chromosomal abnormality, as
in Bloom's syndrome (38), or have undergone extensive aneuploidy as a conse-
quence of prolonged passage in tissue culture (39), introduction of an activated
ras oncogene can induce the full range of transformation characteristics. Our
experience with melanocytes is similar to experience with other diploid human
cell types. Melanocytes infected with ras-containing retroviruses show some
characteristics ofmelanoma, i.e., la expression, augmented GD3 levels, and abilityALBINO ET AL.
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to form colonies in soft agar, but not other melanoma characteristics, i.e., growth
factor independence and loss of adenosine deaminase binding protein. In addi-
tion, melanomas are known to have marked karyotypic abnormalities (40), with
the most common perturbations being hyperdiploid to tetradiploid numbers of
chromosomes, chromosomal rearrangements, nonrandom alterations on chro-
mosomes 1, 6, and 7, and a frequent loss of heterozygosity at loci on many
chromosomes (41), Melanocytes expressing viral ras maintain a diploid karyotype
during early passage. However, by 8-10 wk after infection, some 50% showed
hyperdiploid chromosomal numbers, although no chromosomal rearrangements
were observed. In contrast, amphotropic MuLV-infected melanocytes retain a
normal karyotype, and cultured melanocytes are known to remain euploid for
at least 18 mo (42). It will be important to define the progressive chromosomal
changes that occur in viral ras-containing melanocytes with prolonged passage,
and to determine whether such changes lead to the fully transformed features
of melanoma.
Summary
Human melanocytes infected with Ki-MSV or Ha-MSV, but not amphotropic
MuLV, undergo a series of transformation-related changes that are characteristic
of malignant melanoma. These are (a) expression of la antigens, in particular
DP, DQ, and DR class 11 histocompatibility gene products, (b) a transformed
morphology and ability to grow in soft agar, and (c) a 5-10-fold increase in the
cell surface expression of Gps ganglioside . However, other characteristics of
melanoma, such as independence from specific growth factors and loss of
adenosine deaminase binding protein were not observed. We conclude that viral
ras oncogenes initiate early transformation events in melanocytes, and that la
antigen expression is a transformation marker in this system.
We thank Andrea Herman, Laura Davis, Olga Marko, and Aswani Yenamandra for
expert technical assistance.
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